11-5226978-A-C
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_000518.5(HBB):c.44T>G(p.Leu15Arg) variant causes a missense change. The variant allele was found at a frequency of 0.00000137 in 1,461,162 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000518.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461162Hom.: 0 Cov.: 33 AF XY: 0.00000138 AC XY: 1AN XY: 726914
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Uncertain:2
- -
The Hb Sogn variant (HBB: c.44T>G; p.Leu15Arg, also known as p.L14R when numbered from the mature protein, rs33935445, HbVar ID: 243, ClinVar ID: 15355) is reported in the literature in multiple clinically healthy heterozygous individuals (Fairbanks 1990). This variant has also been reported in heterozygosity in combination with alpha-thal-2 trait in an individual with microcytosis and hypochromia (Miller 1996). This variant does not separate from Hb S during electrophoresis (see link to HbVar and references therein). This variant is reported as mildly unstable (HbVar). This variant is absent from the Genome Aggregation Database, indicating it is not a common polymorphism (v2.1.1). Computational analyses predict that this variant is deleterious (REVEL: 0.797). Due to limited information, the clinical significance of the p.Leu15Arg variant is uncertain at this time. References: Link to HbVar database: https://globin.bx.psu.edu/hbvar/menu.html Miller DR et al. Hb Sogn or alpha 2 beta 2 14(A11)Leu-->Arg in combination with an alpha-thalassemia heterozygosity. Hemoglobin. 1996 May;20(2):131-4. PMID: 8811316 Fairbanks VF et al. Two families with hemoglobin Sogn, beta(A11)14 Leu----Arg, in Minnesota and Indiana: hematologic, functional, and biosynthetic features. Mayo Clin Proc. 1990 Jun;65(6):793-8. PMID: 2366586. -
not specified Uncertain:1
Variant summary: HBB c.44T>G (p.Leu15Arg) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 251236 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.44T>G has been reported in the literature in asymptomatic carriers who were hematologically normal, as well as a heterozygous proband with microcytosis and hypochromia who was also heterozygous with an alpha-thalassemia-2 allele (e.g. Monn_1970, Fairbanks_1990, Miller_1996). These reports do not provide unequivocal conclusions about association of the variant with Hemoglobinopathy. Experimental evidence found that the variant results in a less stable protein than the wild type (Mann_1970, Fairbanks_1990), however, does not allow convincing conclusions about the variant effect. The following publications have been ascertained in the context of this evaluation (PMID: 8811316, 2366586, 4994348). ClinVar contains an entry for this variant (Variation ID: 15355). Based on the evidence outlined above, the variant was classified as uncertain significance. -
beta Thalassemia Uncertain:1
- -
HEMOGLOBIN SOGN Other:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at